uniQure N.V.

QURENASDAQ • USD
23.52 USD
↘ 0.29 (1.23%)🟢PRE MARKET (AS OF 04:07 AM EST)
🟢Market: OPEN

QURE is currently priced at $23.52. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 13, 2026.

Open?$24.05
High?$24.05
Low?$23.52
Prev. Close?$23.81
Volume?457
Avg. Volume?2.0M
VWAP?$23.98
Rel. Volume?0.00x
Bid / Ask
Bid?$19.60 × 100
Ask?$27.87 × 100
Spread?$8.27
Midpoint?$23.74
Valuation & Ratios
Market Cap?1.7B
Shares Out?70.1M
Float?66.1M
Float %?95.4%
P/E Ratio?N/A
P/B Ratio?5.67
EPS?-$3.32
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
Employees
221
Market Cap
1.7B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2014-02-05
Address
PAASHEUVELWEG 25A
AMSTERDAM, 1105 BP
Phone: 1-339-970-7000
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
1
Momentum?
71
Short Sent.?
34
Piotroski F-Score?5/9Mixed
Altman Z-Score?-0.56Distress
Confidence?55%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?12.86%High
Short Interest?8.5M
Days to Cover?6.4
Free Float66.1M
Avg Daily Volume1.3M
Settlement Date2026-10-30
Financial Health
Current Ratio?11.52Strong
Quick Ratio?11.52Strong
Cash Ratio?1.64Strong
Debt/Equity?0.17Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
33
5.67FAIR▾
P/S?
Peers
100
S&P
3
82.81HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-9.3CHEAP▾
EV/Sales?
Peers
100
S&P
3
80.42HIGH▾
Returns & Efficiency
ROE?
S&P
3
-79.0%WEAK▾
ROA?
S&P
3
-24.8%WEAK▾
Cash Flow & Enterprise
FCF?$-192957000
Enterprise Value?$1.6B
Fundamentals ratios updated end of day